Genetic Variants Associated with Clinicopathological Profiles in Sporadic Breast Cancer in Sri Lankan Women.
10.4048/jbc.2018.21.2.165
- Author:
Nirmala Dushyanthi SIRISENA
1
;
Adebowale ADEYEMO
;
Anchala Ishani KURUPPU
;
Nilakshi SAMARANAYAKE
;
Vajira Harshadeva Weerabaddana DISSANAYAKE
Author Information
1. Human Genetics Unit, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka. nirmala@anat.cmb.ac.lk
- Publication Type:Original Article
- Keywords:
Alleles;
Breast neoplasms;
Postmenopause;
Prognosis;
Single nucleotide polymorphism
- MeSH:
Age of Onset;
Alleles;
Asian Continental Ancestry Group;
Biomarkers;
Breast Neoplasms*;
Breast*;
Estrogens;
Female;
Humans;
Logistic Models;
Lymph Nodes;
Polymorphism, Single Nucleotide;
Population Groups;
Postmenopause;
Prognosis;
Receptor, Epidermal Growth Factor;
Receptors, Progesterone
- From:Journal of Breast Cancer
2018;21(2):165-172
- CountryRepublic of Korea
- Language:English
-
Abstract:
PURPOSE: Several single nucleotide polymorphisms (SNPs) have been reported to be associated with clinicopathological profiles in sporadic breast cancer based on studies conducted on major population groups. The knowledge of the effects of these common genetic variants in South Asian populations remains limited. The present study aimed to investigate the association between a selected set of SNPs and the clinicopathological profiles in sporadic breast cancer in Sri Lankan women. METHODS: A total of 350 postmenopausal women with histologically confirmed invasive breast cancer were genotyped for 58 SNPs located in 36 breast cancer related genes. The clinicopathological factors that were investigated included age of onset, tumor histologic grade, and lymph node involvement, as well as estrogen receptor (ER), progesterone receptor, and human epidermal growth factor receptor 2 (HER2) status. Association testing was performed using logistic regression models adjusted for confounding factors. RESULTS: Seven SNPs showed significant associations with clinicopathological profiles in breast cancer. The G allele of BRCA1:rs799917 (p=0.047; β [standard error; SE]=−1.069 [0.537]) and the G allele of NQO2:rs17136117 (p=0.040, β [SE]=1.901 [0.923]) were found to be associated with age of onset between 50 and 59 years. The C allele of CDH1:rs13689 (odds ratio [OR], 2.121; p=0.033) was found to be associated with ER-positive breast cancer. The A allele of AKT1:rs1130214 (OR, 2.095; p=0.011) and the C allele of NQO2:rs2071002 (OR, 1.632; p=0.045) were associated with HER2-positive breast cancer. The C allele of BRCA2:rs15869 (OR, 1.600; p=0.041) and the C allele of CCND1:rs7177 (OR, 1.555; p=0.041) were associated with high tumor histologic grade. CONCLUSION: The common genetic variants identified in the AKT1, BRCA1, BRCA2, CCND1, CDH1, and NQO2 genes could serve as potential clinical and prognostic biomarkers in sporadic breast cancer patients. Further studies are required to validate our current findings in other populations.
